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Abstract: Venous ultrasonography is an indispensable tool in minimally invasive surgery 
for the treatment of varicose veins. However, the criteria for defining preoperative imaging 
parameters, outcome monitoring, and follow up are not well characterized. In this retrospective 
study, we reviewed the ultrasound periprocedural parameters and the outcomes in 274 patients 
(280 limbs) after endoluminal laser treatment, at early (,30 days) and late (1−60 months) follow 
up. Treatment failure was defined as complete recanalization of the saphenous trunk, thigh 
perforator vein insufficiency, and recanalization of the proximal saphenous trunk. Judicious 
patient selection correlated with favorable outcome at the follow-up ultrasound examination.
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Introduction
Venous ultrasonography is an indispensible tool in endoluminal laser treatment 
(ELT) for varicose veins, and it constitutes the first step in this procedure.1−3 A typical 
procedure begins with echo color Doppler ultrasound (US) imaging of the diseased 
vein to trace its location. This step then allows the physician to determine the skin 
puncture site where the needle will be inserted in the vein, as well as to control the 
insertion and endoluminal progression of the wire and the sheath and the placement 
of the laser fiber in the proximity of the saphenofemoral junction. The progression 
of the fiber inside the vessel can also be visualized, to control the laser effect on the 
venous wall. Perivenous tumescent local anesthesia can also be performed under US 
surveillance. Finally, during follow up, echo color Doppler is useful to confirm the 
stable and durable efficacy of treatment, to investigate the etiology of recurrence, or 
to evaluate the progression of chronic venous disease.4 The aim of this study was to 
define standard criteria for monitoring outcomes after ELT.
Materials and methods
Between April 2005 and September 2010, in the Division of Vascular Surgery, 
University of Turin, Italy, 274 patients underwent duplex US  examination prior to 
ELT for great saphenous trunk insufficiency. Echo color Doppler (MyLab™ 25; 
Esaote, Genoa, Italy) was performed immediately before surgery, with the patient in 
an orthostatic position, and a reflux was considered pathologic if lasting longer than 
500 milliseconds. All the procedures were done by two surgeons. A 18G  needle was 
used for percutaneous puncture of the vein; then, a 5F catheter was inserted over a 
0.018 inches guide wire, with US-guided advancement of the catether tip to the internal 
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saphenous arch (just below the superficial epigastric vein 
and within 1.5 cm of the saphenofemoral junction). ELT was 
performed with an 810 nm diode laser wavelength (Diomed 
30W®; Diomed Inc.). All patients gave written informed 
consent in accordance with Helsinki declaration.
The procedure was performed under local anesthesia 
(approximately 100 mL of saline plus 200 mg lidocaine), 
administered subcutaneously to induce tumescence around 
the long saphenous vein segment. Monitored  anesthesia 
care, using midazolam (0.02 mg/kg) and  remifentanil 
(0.025 mcg/kg/min), was administered during the 
procedure.
The treatment power energy was 12 W, and the mean 
power was 70−80 J/cm2 (100 J/cm2 in the first 3 cm from 
the internal saphenous arch). All evident varicosities were 
concurrently treated with phlebectomy.
Early follow-up examination included duplex US  scanning 
at 1, 7, and 30 days; late follow up was performed at 3, 6, and 
12 months after the procedure, then annually. All follow-up 
examinations were performed by the same vascular surgeon.
The Italian Society of Vascular Diagnostics guidelines 
recommend follow-up at 1, 6, and 12 months and then annu-
ally after venous procedures. Closer follow up (1−7 days) 
after ELT will usually reveal early complications (deep 
venous system involvement) and permit the documentation 
of treatment efficacy.5 Because most complications appear 
within 3 months after treatment, an echo color Doppler 
control examination is warranted at this time.6
Early follow-up US examination investigated for 
 endothermal heat-induced thrombosis and deep venous 
thrombosis. The imaging findings indicating favorable out-
come were:
1.	 At the saphenofemoral junction:
 a.  Patency and absence of thrombotic occlusion of the 
common femoral vein
 b.  Occlusion of the saphenous trunk 
 c.  Residual saphenous stump , 3cm  without reflux
	 d.  Patency of the tributary vessels of the saphenous trunk 
in the common femoral vein
2.	 At the saphenous trunk:
 a.  Appearance of a nonechoic lumen suggesting 
thrombosis
 b.  Appearance of an echoic lumen, not compressible and 
without reflux.
Late follow-up examination checked for either evident 
recurrent varicosities (classified as clinically visible or 
palpable varicosities more than 3−4 mm in diameter) or 
echographic evidence of recurrence.
In the present series, after ELT ablation, three types of 
reflux were found:
1.	 Recanalization of a previously occluded saphenous 
trunk
2.	 Neoreflux in an accessory saphenous vein
3.	 Thigh perforator vein insufficiency and recanalization of 
the proximal saphenous trunk.
Independently of clinically evident varicosities, favor-
able outcomes were defined as the complete obliteration of 
the great saphenous vein (GSV) after laser treatment or the 
absence of reflux despite the recanalization of the proxi-
mal segment of the vessel. Furthermore, independently of 
clinically evident varicosities, failure was defined as the com-
plete recanalization of the saphenous trunk with or without 
reflux in the accessory GSV, thigh perforator vein (Dodd’s 
perforator) insufficiency, and recanalization of the proximal 
saphenous trunk. Also, neoreflux in the accessory saphenous 
vein and an increase in the diameter of the leg portion of the 
GSV with the recurrence of varicosities, even after success-
ful obliteration of the saphenous trunk, were both considered 
signs of the progression of venous disease.
Results
Overall, 274 patients (280 limbs) underwent ELT associ-
ated with phlebectomies of the evident varicosities. The 
mean duration of follow up was 26.58 ± 5.7 months (range, 
1−60). Six patients (six limbs) were excluded from the 
final analysis because they did not return for follow-up 
assessment. A recurrence of varicose veins was recorded in 
30 cases (10.9%). Echo color Doppler demonstrated GSV 
recanalization in 13 patients (4.7%); recurrent varicose 
veins occurred in three cases (1.1%), due to neoreflux in the 
anterior accessory saphenous vein and in 14 cases (5.1%), 
due to insufficiency of the perforating veins.
Long-term success (according to the criteria described 
above) was achieved in 261 cases (95.2%), and treatment 
failure was observed in 13 cases. No major complications, such 
as deep vein thrombosis, perforation of veins, or skin burns, 
occurred. Paresthesia developped in six patients: in two cases, 
this was transient, with symptoms resolving after 1 month; in 
four cases, this persisted for 6 months after the operation.
Between postoperative days 7 and 10, perivenous 
inflammatory processes with lymphangitic features in the 
middle third of the thigh developed in ten patients. These 
complications resolved with local therapy within 30 days 
of the procedure.
In eight (61.5%) of the 13 patients with recurrent varicose 
veins due to GSV recanalization, secondary treatment, by 
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US-guided sclerotherapy with sodium 3% tetradecylsulfate 
or 3% polidocanol foam, obtained good immediate results. 
One patient underwent primary crossectomy plus short 
 stripping 1 year after ELT. We successfully treated another 
patient with a secondary ELT about 6 months after the first 
laser treatment. Secondary treatment was not necessary 
in three cases because the symptoms regressed after laser 
treatment. Three patients with recurrent varicose veins due 
to a refluxing accessory anterior saphenous vein underwent 
crossectomy plus phlebectomy, with good results.
Twelve out of 14 patients with recurrence due to 
 perforating veins in the leg underwent sclerotherapy only 
for varicosities, while two patients were asymptomatic 
and were not treated. In three of the patients who received 
US-guided sclerotherapy, the secondary procedure failed 
due to recanalization of the treated vein. These patients 
ultimately underwent open surgery (crossectomy plus short 
stripping).
Conclusion
Long-term US surveillance underscores the importance of 
proper patient selection for ELT, to obtain optimal therapeutic 
outcome, comparable with those in literature.7−12 Furthermore, 
US surveillance has provided evidence that the delivery of 
endovenous fluence equivalent greater than 70−80 J/cm2 is 
correlated with a lower recanalization rate.13−15 Early follow 
up with US is mandatory to exclude major complications, 
such as deep vein thrombosis or perforation of the vein. 
Moreover, late follow up is also important, to distinguish 
between recurrences caused by GSV recanalization from 
those induced by neoreflux in the anterior accessory saphen-
ous vein or by insufficiency of the perforating veins.
During short- and long-term follow up, the criteria for 
defining the procedure success should be differentiated in 
sonographic and clinical parameters. Favorable treatment 
 outcome is  determined not only by the presence or absence 
of recurrent  varicosities, but also by patient satisfaction 
and the improvement of symptoms attributable to venous 
insufficiency.
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